Gracon_1997_Schweiz.Rundsch.Med.Prax_86_1350

Reference

Title : [Advantages in long-term treatment with Cognex in Alzheimer disease] - Gracon_1997_Schweiz.Rundsch.Med.Prax_86_1350
Author(s) : Gracon S , Smith F , Shokry A
Ref : Schweiz Rundsch Med Prax , 86 :1350 , 1997
Abstract :

Early diagnosis and treatment of AD is critical to maximize benefits for the patient and the caregiver. It is important to intervene early in the illness, before the quality of life of the patient and the caregiver has deteriorated to the point where treatment only prolongs an already difficult situation. If treatment begins early enough in the disease course, loss of functional independence may be delayed, just as nursing home placement was delayed in this study. In this way, quality of life is improved for both the patient and the caregiver.

PubMedSearch : Gracon_1997_Schweiz.Rundsch.Med.Prax_86_1350
PubMedID: 9381027

Related information

Inhibitor Tacrine

Citations formats

Gracon S, Smith F, Shokry A (1997)
[Advantages in long-term treatment with Cognex in Alzheimer disease]
Schweiz Rundsch Med Prax 86 :1350

Gracon S, Smith F, Shokry A (1997)
Schweiz Rundsch Med Prax 86 :1350